NCT03306264 2024-08-27
Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML
Astex Pharmaceuticals, Inc.
Phase 3 Completed
Clinical Trials
1 trialsHas announcements × Leukemia, Myelomonocytic, Chronic × decitabine and cedazuridine drug combination × Clear all